Top Clinical Trials companies in Japan by Operating Cash Flow
Japan
# |
Name |
Operating Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 4.73 B
|
March 31, 2024 | USD 27.51 | 2.57% |
|
Japan |
|
| 2 |
USD 2.91 B
|
Dec. 31, 2023 | USD 44.59 | 2.75% |
|
Japan |
|
| 3 |
USD 1.14 B
|
March 31, 2024 | USD 9.46 | 1.16% |
|
Japan |
|
| 4 |
USD 1.02 B
|
March 31, 2024 | USD 14.57 | 3.59% |
|
Japan |
|
| 5 |
USD 818.91 M
|
Dec. 31, 2023 | USD 14.79 | 0.14% |
|
Japan |
|
| 6 |
USD 479.99 M
|
March 31, 2024 | USD 9.63 | -2.79% |
|
Japan |
|
| 7 |
USD 89.41 M
|
March 31, 2024 | USD 10.19 | 8.20% |
|
Japan |
|
| 8 |
USD 88.03 M
|
Dec. 31, 2023 | USD 13.30 | 2.22% |
|
Japan |
|
| 9 |
USD 61.52 M
|
March 31, 2024 | USD 3.30 | 4.32% |
|
Japan |
|
| 10 |
USD 51.76 M
|
June 30, 2024 | USD 8.40 | 1.17% |
|
Japan |
|
| 11 |
USD 46.42 M
|
Dec. 31, 2023 | USD 22.68 | 5.69% |
|
Japan |
|
| 12 |
USD 29.69 M
|
March 31, 2024 | USD 11.55 | 2.65% |
|
Japan |
|
| 13 |
USD 28.88 M
|
Sept. 30, 2024 | USD 9.59 | 3.33% |
|
Japan |
|
| 14 |
USD 22.68 M
|
March 31, 2024 | USD 15.35 | 0.99% |
|
Japan |
|
| 15 |
USD 13.92 M
|
March 31, 2024 | USD 12.27 | 5.66% |
|
Japan |
|
| 16 |
USD 10.23 M
|
March 31, 2024 | USD 9.13 | -1.99% |
|
Japan |
|
| 17 |
USD 7.04 M
|
March 31, 2024 | USD 2.30 | 4.06% |
|
Japan |
|
| 18 |
USD 2.95 M
|
March 31, 2024 | USD 18.44 | 0.77% |
|
Japan |
|
| 19 |
USD -75.66 K
|
March 31, 2024 | USD 1.65 | 22.29% |
|
Japan |
|
| 20 |
USD -523.98 K
|
March 31, 2024 | USD 2.10 | -1.79% |
|
Japan |
|
| 21 |
USD -1.38 M
|
Dec. 31, 2023 | USD 1.21 | 0.22% |
|
Japan |
|
| 22 |
USD -2.54 M
|
Dec. 31, 2023 | USD 0.25 | 3.49% |
|
Japan |
|
| 23 |
USD -3.87 M
|
March 31, 2024 | USD 0.93 | 0.77% |
|
Japan |
|
| 24 |
USD -5.09 M
|
Dec. 31, 2023 | USD 2.65 | 4.67% |
|
Japan |
|
| 25 |
USD -5.48 M
|
June 30, 2024 | USD 1.00 | 0.77% |
|
Japan |
|
| 26 |
USD -7.61 M
|
March 31, 2024 | USD 5.69 | -0.47% |
|
Japan |
|
| 27 |
USD -8.11 M
|
March 31, 2024 | USD 0.17 | 4.80% |
|
Japan |
|
| 28 |
USD -9.47 M
|
Dec. 31, 2023 | USD 3.66 | 1.69% |
|
Japan |
|
| 29 |
USD -11.08 M
|
March 31, 2024 | USD 24.56 | 1.18% |
|
Japan |
|
| 30 |
USD -11.89 M
|
Dec. 31, 2023 | USD 1.91 | 2.54% |
|
Japan |
|
| 31 |
USD -32.51 M
|
Jan. 31, 2024 | USD 5.34 | 6.29% |
|
Japan |
|
| 32 |
USD -37.37 M
|
Dec. 31, 2023 | USD 6.35 | 2.58% |
|
Japan |
Frequently Asked Questions
-
Which Clinical Trials company in Japan has the highest Operating Cash Flow ?
The Clinical Trials company in Japan with the highest Operating Cash Flow is Takeda Pharmaceutical Company Limited (Tokyo Stock Exchange: 4502.T) at USD 4.73 B.
-
Which Clinical Trials company in Japan has the lowest Operating Cash Flow ?
The Clinical Trials company in Japan with the lowest Operating Cash Flow is Nxera Pharma Co., Ltd. (Tokyo Stock Exchange: 4565.T) at USD -37.37 M.
-
What are the top 10 Clinical Trials companies in Japan by Operating Cash Flow ?
The top 10 Clinical Trials companies in Japan by Operating Cash Flow are Takeda Pharmaceutical Company Limited, Chugai Pharmaceutical Co., Ltd., Astellas Pharma Inc., Shionogi & Co., Ltd., Kyowa Kirin Co., Ltd., Santen Pharmaceutical Co., Ltd., Qol Holdings Co., Ltd., PeptiDream Inc., JCR Pharmaceuticals Co., Ltd. and Macromill, Inc..
-
What are the bottom 10 Clinical Trials companies in Japan by Operating Cash Flow ?
The bottom 10 Clinical Trials companies in Japan by Operating Cash Flow are Nxera Pharma Co., Ltd., SanBio Company Limited, Carna Biosciences, Inc., Kissei Pharmaceutical Co., Ltd., Oncolys BioPharma Inc., OncoTherapy Science, Inc., Cytori Cell Research Institute, Inc., Soiken Holdings Inc., RaQualia Pharma Inc. and NanoCarrier Co., Ltd..
